Ireland HIV Therapeutics Market Analysis

Ireland HIV Therapeutics Market Analysis


$ 3999

By 2030, it is anticipated that the Ireland HIV therapeutics market will reach a value of $xx Mn from $xx Mn in 2022, growing at a CAGR of xx% during 2022-2030. The market is primarily dominated by local players such as Gilead Sciences, Pfizer, and Gilead Sciences. The market is driven by government policies and non-governmental organizations’ initiatives for the management of HIV infections in the country. The HIV therapeutics market in Ireland is segmented by type, product, and geography, end user, and distribution channel.

ID: IN10IEPH037 CATEGORY: Pharmaceuticals GEOGRAPHY: Ireland AUTHOR: Dr. Vishwa Modhia

Buy Now

Ireland HIV Therapeutics Market Analysis Summary

By 2030, it is anticipated that the Ireland HIV therapeutics market will reach a value of $xx Mn from $xx Mn in 2022, growing at a CAGR of xx% during 2022-2030.

Ireland is an island nation located in Western Europe, northwest of the United Kingdom. The number of HIV/AIDS-related deaths in Ireland will reach 100 in 2020, according to the most recent WHO data. With a death rate of 0.15 per 100,000 people when adjusted for age, Ireland is ranked 150th in the world. With 7800 HIV cases in 2020, Ireland's adult prevalence of HIV/AIDS was 0.3% in 2021, placing it in 78th place globally.

In 2019, Ireland's GDP was allocated to healthcare at 7.1%. HIV Ireland is the organization that manages HIV/AIDS cases in Ireland. More than 750 cases of HIV have been reported in 2022, according to statistics released by the Health Protection Surveillance Centre. This is more than twice as many cases as were reported during the same time period in 2021.

Market Dynamics

Market Growth Drivers

The Irish government funds and supports HIV care, including ART access, which has boosted the uptake of these medications. In order to ensure that Ireland can fulfill its international commitment to stop new HIV transmissions, the government organization HIV Ireland recently called for increased funding for all national sexual health services, including personnel and resources. These elements may stimulate Ireland’s market for HIV therapeutics.

Market Restraints

Although the quality of healthcare in Ireland is generally high, waiting lists and costs limit access to services. Access to testing, care, and treatment for people living with HIV continues to be severely hampered in Ireland due to stigma and discrimination.

Competitive Landscape

Key Players

  • Bristol-Myers Squibb
  • Pfizer
  • Gilead Sciences
  • Merck & Co
  • ViiV Healthcare
  • Roche
  • AstraZeneca

Recent Notable Updates

October 2020: Due to the ongoing Covid-19 pandemic, one of Ireland's biggest suppliers of HIV preventive medication has permanently closed. All of the current users of the Gay Men's Health Service (GMHS) were urged to schedule appointments with alternative PrEP (Pre-Exposure Prophylaxis) services yesterday.

Healthcare Regulations and Reimbursement Policies

The approval and distribution of antiretroviral drugs used to treat HIV are governed by the Health Products Regulatory Authority (HPRA), a regulatory body in Ireland. The HPRA is solely in charge of regulating pharmaceuticals and medical devices in Ireland. The HPRA reviews antiretroviral drugs for efficacy, quality, and safety before deciding whether to approve them for use in Ireland. The HPRA works closely with the European Medicines Agency (EMA), as well as other national and international regulatory bodies, to ensure the effectiveness and safety of antiretroviral medications for use in Ireland.

The Health Service Executive (HSE), Ireland's public health system, is primarily responsible for paying for antiretroviral medications used to treat HIV. The government funds the HSE, which is in charge of offering healthcare services to Ireland's citizens. The majority of antiretroviral medications can be obtained from the HSE and are given without charge to patients who have a prescription from a healthcare professional. The cost of antiretroviral medications in Ireland may also be covered by private health insurance in addition to the public healthcare system.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

HIV Therapeutics Segmentation

By Types (Revenue, USD Billion):

  • Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
  • Coreceptor Antagonists
  • Entry and Fusion Inhibitors
  • Integrase Inhibitors
  • Protease Inhibitors (PIs)
  • Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

By Distribution Channel (Revenue, USD Billion):

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 18 February 2023
Updated by: Vidhi Upadhyay

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up